Correspondence 0001493152-23-015975 from Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences, Inc.
Date: May 9, 2023 · CIK: 0001716947 · Accession: 0001493152-23-015975

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-271480

Date

May 9, 2023

Author

Chief

Form

CORRESP

Company

Ensysce Biosciences, Inc.

Letter

Re: Ensysce Bioscience, Inc.

May 9,

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

Registration Statement on Form S-1 (Registration No. 333-271480) -

Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-271480) (the “Registration Statement”), hereby concurs in the request by Ensysce Bioscience, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Tuesday, May 9, 2023, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text

CORRESP
1
filename1.htm

  May 9,
  2023

VIA
FACSIMILE AND EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporate Finance

Washington,
DC 20549

    Re:
    Ensysce
    Bioscience, Inc.

    Registration
    Statement on Form S-1 (Registration No. 333-271480) -

    Concurrence
    in Acceleration Request

Ladies
and Gentlemen:

H.C.
Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best-efforts basis in an offering
pursuant to the registration statement on Form S-1 (333-271480) (the “Registration Statement”), hereby concurs in
the request by Ensysce Bioscience, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00
P.M. Eastern Time on Tuesday, May 9, 2023, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright
affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration
Statement.

    Very truly yours,

    H.C. WAINWRIGHT & CO., LLC

    By:

    /s/
    Edward D. Silvera

    Name:

    Edward
    D. Silvera

    Title:

    Chief
    Operating Officer

430
Park Avenue | New York, NY 10022 | 212.356.0500 | www.hcwco.com

Member:
FINRA/SIPC

SecProbe.io